3 Stocks Pushing The Health Services Industry Higher

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 9 points (-0.1%) at 14,437 as of Tuesday, March 12, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,094 issues advancing vs. 1,829 declining with 130 unchanged.

The Health Services industry currently is unchanged today versus the S&P 500, which is down 0.3%. Top gainers within the industry include Life Technologies ( LIFE), up 2.3%, Aetna ( AET), up 1.5%, UnitedHealth Group ( UNH), up 1.2%, Smith & Nephew ( SNN), up 0.8% and WellPoint ( WLP), up 0.5%. On the negative front, top decliners within the industry include Intuitive Surgical ( ISRG), down 1.0%, Baxter International ( BAX), down 0.8% and Edwards Life ( EW), down 0.5%.

TheStreet Ratings group would like to highlight 3 stocks pushing the industry higher today:

3. DexCom ( DXCM) is one of the companies pushing the Health Services industry higher today. As of noon trading, DexCom is up $0.97 (6.2%) to $16.54 on heavy volume Thus far, 448,186 shares of DexCom exchanged hands as compared to its average daily volume of 373,400 shares. The stock has ranged in price between $15.78-$16.63 after having opened the day at $15.81 as compared to the previous trading day's close of $15.57.

DexCom, Inc., a medical device company, engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes, and for use by healthcare providers in the hospital for the treatment of diabetic and non-diabetic patients. DexCom has a market cap of $1.1 billion and is part of the health care sector. Shares are up 17.4% year to date as of the close of trading on Monday. Currently there are 8 analysts that rate DexCom a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates DexCom as a sell. Among the areas we feel are negative, one of the most important has been an overall disappointing return on equity. Get the full DexCom Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

2. As of noon trading, St Jude Medical ( STJ) is up $0.29 (0.7%) to $42.99 on light volume Thus far, 1.0 million shares of St Jude Medical exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $42.55-$43.10 after having opened the day at $42.62 as compared to the previous trading day's close of $42.70.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. St Jude Medical has a market cap of $12.0 billion and is part of the health care sector. The company has a P/E ratio of 17.7, equal to the S&P 500 P/E ratio of 17.7. Shares are up 18.2% year to date as of the close of trading on Monday. Currently there are 12 analysts that rate St Jude Medical a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full St Jude Medical Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

1. As of noon trading, Thermo Fisher Scientific ( TMO) is up $0.44 (0.6%) to $77.66 on light volume Thus far, 613,951 shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $76.95-$77.74 after having opened the day at $77.08 as compared to the previous trading day's close of $77.22.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $27.6 billion and is part of the health care sector. The company has a P/E ratio of 22.5, above the S&P 500 P/E ratio of 17.7. Shares are up 21.1% year to date as of the close of trading on Monday. Currently there are 14 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Thermo Fisher Scientific Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.
null